Published by ChinaMNC · Xihua

China’s Health Sector Reforms: What Foreign Founders Need to Know

A high-level national health conference in Beijing signals priorities for healthcare, preventive care, and medical reform during the 15th Five-Year Plan. For foreign founders, the takeaways relate to company registration in health-related sectors, compliance, and long-term planning.

Key Takeaways for Foreign Founders

• Health sector opportunities: China’s leadership reaffirmed the goal of building a “Healthy China” by 2035, with emphasis on preventive care, medical services, traditional medicine, and health industry innovation. This may create openings for foreign businesses in healthcare, wellness, and related technology.
• Policy continuity: The 15th Five-Year Plan period (2026–2030) is described as critical for achieving health goals. Foreign founders should monitor sector-specific regulations and licensing requirements that may evolve.
• Compliance focus: The conference highlighted food safety, drug quality, and medical insurance reforms—areas where foreign companies operating in China must maintain strict compliance.
• No direct registration changes: The source does not announce new procedures for foreign company registration. Founders should continue to follow existing rules for entity setup and sector approvals.

What the Conference Means for Your China Registration

The National Health Conference, held in Beijing on October 12–13, 2026, set broad policy directions but did not introduce specific measures affecting foreign investment registration. For foreign founders, the practical implications are indirect: the government’s health priorities may influence licensing, incentives, or regulatory scrutiny in certain industries.

Healthcare and Medical Services

President Xi Jinping emphasized improving medical service capacity, including primary care, chronic disease management, and integrated traditional Chinese and Western medicine. Foreign investors interested in clinics, hospitals, or telemedicine should note that healthcare is a restricted sector; joint ventures or wholly foreign-owned entities may be permitted only in specific pilot free trade zones and subject to local health commission approvals. The conference did not alter these restrictions, so standard registration and licensing processes apply.

Health Industry and Innovation

The speech called for strengthening basic research and commercialization in health, and for expanding the health industry. This could benefit foreign companies in pharmaceuticals, medical devices, and health technology. However, registration for such businesses typically requires additional licenses (e.g., drug manufacturing, medical device operation) from the National Medical Products Administration (NMPA). Founders should factor in these approvals when planning timelines.

Preventive Care and Food Safety

Prevention was highlighted as the most cost-effective strategy, with calls to improve food safety supervision and disease control. For foreign founders in food and beverage, dietary supplements, or health foods, compliance with China’s food safety laws is critical. The conference did not announce new rules, but existing registration and labeling requirements remain stringent.

Medical Insurance and Drug Procurement

Reforms to medical insurance, centralized drug procurement, and the national essential medicines system were emphasized. Foreign companies selling pharmaceuticals or medical devices to public hospitals should understand these procurement mechanisms, which can affect pricing and market access. Company registration itself is separate, but sector-specific tendering and insurance listing processes may require local partnerships or representative offices.

“One Belt One Road” Health Cooperation

The conference mentioned deepening health cooperation under the Belt and Road Initiative. This may create opportunities for foreign firms in health infrastructure, training, or telemedicine projects, but such engagements often involve government-to-government arrangements or partnerships with Chinese entities. Setting up a local company can facilitate participation, but specific project approvals are needed.

Practical Steps for Foreign Founders

• Choose the right entity: For health-related businesses, a wholly foreign-owned enterprise (WFOE) is common, but restricted sectors may require a joint venture. Consulting with local authorities is advisable.
• Secure sector approvals first: Before registering, obtain necessary pre-approvals from health, drug, or food regulators, as these can be time-consuming.
• Understand capital requirements: There is no universal minimum capital, but certain licensed activities (e.g., medical institutions) may have specific capital thresholds. The source does not provide details, so verify with local regulations.
• Plan for compliance: Ensure ongoing adherence to food safety, drug quality, and medical insurance rules, which are subject to inspection.
• Monitor policy developments: The 15th Five-Year Plan may bring further sector-specific rules; stay informed through official channels.

Conclusion

The National Health Conference reaffirms China’s focus on health sector development, which may open opportunities for foreign businesses. However, company registration and operation in these fields require careful navigation of licensing and compliance. Foreign founders should conduct thorough due diligence and seek local expertise.

This summary is based on information published by the relevant Chinese government website and is general information, not legal or tax advice.

Call to action: For assistance with registering and operating a company in China, foreign founders can contact ChinaMNC on WhatsApp / WeChat at +86 153 1898 8535.